Embecta (FRA:JX7) Debt-to-Asset : 1.36 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Debt-to-Asset?

Embecta's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €12 Mil. Embecta's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1,493 Mil. Embecta's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €1,104 Mil. Embecta's debt to asset for the quarter that ended in Mar. 2024 was 1.36.

Embecta Debt-to-Asset Historical Data

The historical data trend for Embecta's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Debt-to-Asset Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Asset

1.51

1.35

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial											1.36	1.31	1.35	1.34	1.36

Competitive Comparison of Embecta's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Embecta's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Embecta's Debt-to-Asset falls into.

Embecta Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Embecta's Debt-to-Asset for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(12.275	+	1523)	/	1137.893
	=	1.35

Embecta's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(12.144	+	1492.792)	/	1103.632
	=	1.36

Embecta (FRA:JX7) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Embecta Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Embecta's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines